Podcast: Ocugen CEO Musunuri On Gene Therapy Candidates, The Omicron Advantage

Phase I Trials For OCU-400 Set For Q1 2022

 
• By Vibha Ravi
Scrip Podcast Special
Ocugen's Founder-CEO Shankar Musunuri In Conversation With Scrip

More from R&D

More from Scrip